Clinical Significance

CA 19-9 is a tumor-associated antigen that is elevated mostly in patients with Advanced Pancreatic Cancer. It may also be elevated in other cancers, conditions, diseases such as colorectal cancer, lung cancer, gall bladder cancer, gallstones, pancreatitis, cystic fibrosis, and liver disease. Although, increase in the levels of CA 19-9 is not distinctively suggestive of pancreatic cancer, currently, it is the single most useful blood test to differentiate benign disorders from the malignant ones.

[su_spoiler title=”Technique” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]

C.L.I.A

[/su_spoiler]

[su_spoiler title=”Who Prescribes” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]

General physician, General Medicine, gastroenterologist, oncologist

[/su_spoiler]

[su_spoiler title=”Reporting Tat” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]

 

12[/su_spoiler]

[su_spoiler title=”Sample Type” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]

SERUM

[/su_spoiler]

[su_spoiler title=”Fasting” open=”no” style=”default” icon=”plus” anchor=”” anchor_in_url=”no” class=””]

N

[/su_spoiler]

Reviews

There are no reviews yet.

Be the first to review “CA 19.9”

Your email address will not be published.

No more offers for this product!

General Inquiries

There are no inquiries yet.